Drug-drug interactions in oncology - prevalence and clinical relevance

被引:0
|
作者
Hinnerkort, A. [1 ,2 ]
Liekweg, A. [1 ]
Muellerleile, U. [3 ]
Tiede, S. [3 ]
Bruellke, N. [3 ]
Jaehde, U. [2 ]
机构
[1] Asklepios Kliniken Hamburg GmbH, Dept Pharm, Hamburg, Germany
[2] Univ Bonn, Dept Clin Pharm, Inst Pharm, D-5300 Bonn, Germany
[3] Asklepios Klin Barmbek, Dept Oncol & Pallit Med, Hamburg, Germany
来源
ONKOLOGIE | 2010年 / 33卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1 / 1
页数:1
相关论文
共 50 条
  • [41] Drug-drug interactions
    Preskorn, SH
    JOURNAL OF CLINICAL PSYCHIATRY, 1996, 57 (05) : 223 - 225
  • [42] Prevalence of potential drug-drug interactions in Swedish pediatric outpatients
    Holm, Johan
    Eiermann, Birgit
    Kimland, Elin
    Mannheimer, Buster
    PLOS ONE, 2019, 14 (08):
  • [43] PREVALENCE AND PREDICTORS OF POTENTIALLY SIGNIFICANT DRUG-DRUG INTERACTIONS IN THE ELDERLY
    Dudash, K.
    Negri, G.
    Baccarini, S.
    Rabinowitz, C.
    Maio, V
    VALUE IN HEALTH, 2011, 14 (03) : A7 - A7
  • [44] Prevalence of Drug-Drug Interactions among Hospitalized Cardiac Patients
    Acharya, Leelavathi D.
    Patel, V. K.
    Thiyagu, R.
    Padmakumar, R.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 71 (02) : 223 - 223
  • [45] Clinical Relevance of Drug-Drug InteractionsA Structured Assessment Procedure
    Eric N. van Roon
    Sander Flikweert
    Marianne le Comte
    Pim N.J. Langendijk
    Wilma J.M. Kwee-Zuiderwijk
    Paul Smits
    Jacobus R.B.J. Brouwers
    Drug Safety, 2005, 28 : 1131 - 1139
  • [46] The prevalence of potential drug-drug interactions in adults with intellectual disability
    McMahon, M.
    Hatton, C.
    Bowring, D. L.
    Hardy, C.
    Preston, N. J.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2021, 65 (10) : 930 - 940
  • [47] Clinical Studies of Drug-Drug Interactions: Design and Interpretation
    Greenblatt, David J.
    von Moltke, Lisa L.
    ENZYME- AND TRANSPORTER-BASED DRUG-DRUG INTERACTIONS: PROGRESS AND FUTURE CHALLENGES, 2010, : 625 - 649
  • [48] Clinical Weighting of Drug-Drug Interactions in Hospitalized Elderly
    Juarez-Cedillo, Teresa
    Martinez-Hernandez, Cynthia
    Hernandez-Constantino, Angel
    Carlos Garcia-Cruz, Juan
    Avalos-Mejia, Annia M.
    Sanchez-Hurtado, Luis A.
    Islas Perez, Valentin
    Hansten, Philip D.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 118 (04) : 298 - 305
  • [49] The clinical pharmacist as a detective tracing drug-drug interactions
    De Winter, S.
    Decoutere, L.
    Deman, H.
    Spriet, I.
    Willems, L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 246 - 246
  • [50] Telaprevir: Clinical Pharmacokinetics, Pharmacodynamics, and Drug-Drug Interactions
    Kiang, Tony K. L.
    Wilby, Kyle J.
    Ensom, Mary H. H.
    CLINICAL PHARMACOKINETICS, 2013, 52 (07) : 487 - 510